MedWatch

Novo skeptical about sharing data with rivals

A new tendency in the biotech and pharmaceutical industry – embraced by Lundbeck among others – sees companies sharing research data with competitors in a bid to secure more data for clinical studies. But the Head of Development in Novo Nordisk does not see the purpose of such collaborations.

Foto: Lundbeck/PR

It is becoming increasingly expensive and difficult to find treatments for diseases. As a consequence several pharmaceutical companies have teamed up with competitors and started sharing clinical data, so the total pool of data becomes greater for everyone involved.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

FDA godkender mikrobiommiddel fra Ferring

Medicinalselskabet Ferring Pharmaceuticals har fået amerikansk godkendelse af sin biologiske kandidat mod tarminfektioner med den ondartede bakterie clostridium difficile.

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier